Plasma miR-141-3p as a Potential Diagnostic Biomarker for Early Breast Cancer and a Functional Regulator with Tumor-Suppressive Effects in Luminal A Breast Cancer Cells.
Circulating miR-141-3p shows promise as a non-invasive biomarker for BC detection and risk discrimination, although its specificity as a stand-alone marker may be limited.